Telemedicine, Telehealth, and e-Health Technologies in Cancer Prevention

Lopez, Ana Maria

doi:10.1007/978-3-642-38983-2_9

Cited by 7 publications

(4 citation statements)

References 70 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Telemedicine, which literally means “healing at a distance” [ 120 ], could be understood as the delivery of health care services aiming to advance personal and population health [ 121 ]. Telemedicine allows timely, accessible, and cost-effective health care delivery to the patients, which renders itself a practical solution to COVID-19–induced constraints such as social distancing and self-isolation [ 122 - 124 ]. Telemedicine tools such as virtual reality devices have been found to be useful for training health care practitioners [ 125 ].…”

Section: Opportunities and Solutionsmentioning

confidence: 99%

The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities

Cancino¹,

Su²,

Mesa³

et al. 2020

JMIR Cancer

121

124

View full text Add to dashboard Cite

Cancer is a leading cause of death in the United States and across the globe. Cancer screening is an effective preventive measure that can reduce cancer incidence and mortality. While cancer screening is integral to cancer control and prevention, due to the COVID-19 outbreak many screenings have either been canceled or postponed, leaving a vast number of patients without access to recommended health care services. This disruption to cancer screening services may have a significant impact on patients, health care practitioners, and health systems. In this paper, we aim to offer a comprehensive view of the impact of COVID-19 on cancer screening. We present the challenges COVID-19 has exerted on patients, health care practitioners, and health systems as well as potential opportunities that could help address these challenges.

show abstract

Section: Opportunities and Solutionsmentioning

confidence: 99%

The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities

Cancino¹,

Su²,

Mesa³

et al. 2020

JMIR Cancer

121

124

View full text Add to dashboard Cite

show abstract

“…The COVID-19 pandemic led to a major shift in the way cancer care was provided to patients for a sustained period. As there have been calls for teleoncology to be more present in cancer care [5,6], it is important to understand this almost universal experience of teleoncology from the perspective of clinicians delivering care. After conducting 21 interviews with oncology clinicians about their experiences pivoting to teleoncology during COVID-19, we found that utilization of the technology has many benefits but also has several challenges to be overcome if it is to continue as a viable option for appointments and consultations.…”

Section: Principal Findingsmentioning

confidence: 99%

“…Telemedicine, defined by the Institute of Medicine as the use of electronic information and communications technologies to provide and support health care when distance separates the participants [1], was not often utilized in cancer care prior to COVID-19 [2][3][4]. Although advocates of telemedicine called for improved access to the technology before COVID-19 [5][6][7], the pandemic forced health systems to rapidly adapt. For instance, a study evaluating claims data found that telemedicine utilization for office visits and outpatient care was 78 times higher in April 2020 than in February 2020 among various diseases, including cancer [8].…”

Section: Introductionmentioning

confidence: 99%

Clinicians’ Perceptions of the Benefits and Challenges of Teleoncology as Experienced Through the COVID-19 Pandemic: Qualitative Study

Alpert¹,

Taylor²,

Hampton³

et al. 2022

JMIR Cancer

View full text Add to dashboard Cite

Background COVID-19 thrust both patients and clinicians to use telemedicine in place of traditional in-person visits. Prepandemic, limited research had examined clinician-patient communication in telemedicine visits. The shift to telemedicine in oncology, or teleoncology, has placed attention on how the technology can be utilized to provide care for patients with cancer. Objective Our objective was to describe oncology clinicians’ experiences with teleoncology and to uncover its benefits and challenges during the first 10 months of the COVID-19 pandemic. Methods In-depth, semistructured qualitative interviews were conducted with oncology clinicians. Using an inductive, thematic approach, the most prevalent themes were identified. Results In total, 21 interviews with oncology clinicians revealed the following themes: benefits of teleoncology, such as (1) reducing patients’ travel time and expenses, (2) limiting COVID-19 exposure, and (3) enabling clinicians to “see” a patients’ lifestyle and environment, and challenges, such as (1) technological connection difficulties, (2) inability to physically examine patients, and (3) patients’ frustration related to clinicians being late to teleoncology appointments. Conclusions Teleoncology has many benefits and is well suited for specific types of appointments. Challenges could be addressed through improved communication when scheduling appointments to make patients aware about what to expect. Ensuring patients have the proper technology to participate in teleoncology and an understanding about how it functions are necessary.

show abstract

“…Telemedicine, literally means "healing at a distance" [40], could be understood as the delivery of health care services aiming to advance personal and population health [41]. Telemedicine allows timely, accessible, and cost-effective health care delivery to patients, which qualifies itself a practical solution to the COVID-19-induced constraints such as social distancing and self-isolation [42][43][44]. Telemedicine tools such as virtual reality devices have been found to be useful for training health care practitioners [45].…”

Section: Opportunities and Solutions A) Use Of Telemedicine For Cancer Screening And Preventionmentioning

confidence: 99%

Impact of COVID-19 Pandemic on Cancer Screening in India: Current Situation, Challenges and Way Forwards

Bashar

Begam²

2021

Asian Pac J Cancer Care

View full text Add to dashboard Cite

Cancer screening is a highly effective preventive measure that can reduce cancer incidence and mortality. COVID-19 pandemic has severely disrupted the ongoing screening activities for early diagnosis of cancers across the globe and the worst affected are low and middle income countries and India is no exception to it. This disruption to cancer screening services may have a significant impact on patients, health care practitioners, and health systems. Through this paper, we aim to offer a comprehensive view on the impact of COVID-19 on cancer screening in India and offer potential solutions to the problems arising out of the COVID-19 pandemic in cancer screening and prevention.

show abstract

Telemedicine, Telehealth, and e-Health Technologies in Cancer Prevention

Cited by 7 publications

References 70 publications

The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities

The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities

Clinicians’ Perceptions of the Benefits and Challenges of Teleoncology as Experienced Through the COVID-19 Pandemic: Qualitative Study

Impact of COVID-19 Pandemic on Cancer Screening in India: Current Situation, Challenges and Way Forwards

Contact Info

Product

Resources

About